What's new

Human medicines European public assessment report (EPAR): Epysqli, Date of authorisation: 26/05/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Epysqli, Date of authorisation: 26/05/2023, Revision: 3, Status: Authorised

Apr 16, 2025 - 15:37
 0
Human medicines European public assessment report (EPAR): Epysqli, Date of authorisation: 26/05/2023, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Epysqli, Date of authorisation: 26/05/2023, Revision: 3, Status: Authorised
Read More

Tags:

Previous Article

Hyundai Reveals 2026 Palisade With New Hybrid and XRT Variants

Next Article

SMRs, not large reactors, are ‘future of nuclear power’: ITIF

Related Posts

Human medicines European public assessment report (EPAR): Respreeza, alpha1-proteinase inhibitor (human), Date of authorisation: 20/08/2015, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025  0

PSUSA/00000048/202406

PSUSA/00000048/202406

Mar 7, 2025  0

Human medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025  0